Get Real Time Here
| Open1.270 | Close1.260 |
| Vol / Avg.658.616K / 978.290K | Mkt Cap66.885M |
| Day Range1.240 - 1.270 | 52 Wk Range0.250 - 1.400 |
Zynerba Pharmaceuticals Stock (NASDAQ:ZYNE), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Zynerba Pharmaceuticals (ZYNE)?
There have been no specific sales or earnings guidance reported for Zynerba Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
Zynerba Pharmaceuticals Stock (NASDAQ:ZYNE), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Zynerba Pharmaceuticals (ZYNE)?
There have been no specific sales or earnings guidance reported for Zynerba Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
Zynerba Pharmaceuticals Stock (NASDAQ:ZYNE), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Zynerba Pharmaceuticals (ZYNE)?
There have been no specific sales or earnings guidance reported for Zynerba Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
Zynerba Pharmaceuticals Stock (NASDAQ:ZYNE), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Zynerba Pharmaceuticals (ZYNE)?
There have been no specific sales or earnings guidance reported for Zynerba Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
Zynerba Pharmaceuticals Stock (NASDAQ:ZYNE), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Zynerba Pharmaceuticals (ZYNE)?
There have been no specific sales or earnings guidance reported for Zynerba Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
Zynerba Pharmaceuticals Stock (NASDAQ:ZYNE), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Zynerba Pharmaceuticals (ZYNE)?
There have been no specific sales or earnings guidance reported for Zynerba Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
Zynerba Pharmaceuticals Stock (NASDAQ:ZYNE), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Zynerba Pharmaceuticals (ZYNE)?
There have been no specific sales or earnings guidance reported for Zynerba Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
Zynerba Pharmaceuticals Stock (NASDAQ:ZYNE), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Zynerba Pharmaceuticals (ZYNE)?
There have been no specific sales or earnings guidance reported for Zynerba Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
Zynerba Pharmaceuticals Stock (NASDAQ:ZYNE), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Zynerba Pharmaceuticals (ZYNE)?
There have been no specific sales or earnings guidance reported for Zynerba Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.